Probiotics as Complementary Treatment for Metabolic Disorders
about
Novel perspectives on therapeutic modulation of the gut microbiotaModulation of Tryptophan/Serotonin Pathway by Probiotic Supplementation in Human Immunodeficiency Virus-Positive Patients: Preliminary Results of a New Study Approach.Significance of Microbiota in Obesity and Metabolic Diseases and the Modulatory Potential by Medicinal Plant and Food IngredientsAlterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials.Intestinal removal of free fatty acids from hosts by Lactobacilli for the treatment of obesity.Gut Endotoxin Leading to a Decline IN Gonadal function (GELDING) - a novel theory for the development of late onset hypogonadism in obese men.Gnotobiotic mouse model's contribution to understanding host-pathogen interactions.Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification.Nutritional advice for community patients: insights from a panel discussion.Oral spore-based probiotic supplementation was associated with reduced incidence of post-prandial dietary endotoxin, triglycerides, and disease risk biomarkers.Impact of supplementation with a food-derived microbial community on obesity-associated inflammation and gut microbiota composition.Adaptation and Probiotic Potential of Lactobacilli, Isolated from the Oral Cavity and Intestines of Healthy People.Pterostilbene-induced changes in gut microbiota composition in relation to obesity.Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: a randomized clinical trial.Effects of weight loss using supplementation with Lactobacillus strains on body fat and medium-chain acylcarnitines in overweight individuals.Regulation of immunometabolism in adipose tissue.Synthetic Biology Approaches to Engineer Probiotics and Members of the Human Microbiota for Biomedical Applications.Dose-Dependent Effects of Multispecies Probiotic Supplementation on the Lipopolysaccharide (LPS) Level and Cardiometabolic Profile in Obese Postmenopausal Women: A 12-Week Randomized Clinical Trial.Immunomodulatory Effects of Probiotics on Cytokine Profiles
P2860
Q26745706-07D4E0F0-DDD3-4303-B444-1466CF0DC245Q33758418-765C9525-255E-45E0-9F5F-3FDBF99904B6Q33858968-CD6BBAA6-0A83-4C18-ABDD-4ACF858040DBQ36012463-64771A02-776D-48EC-840B-C7261AB29B95Q36694416-0D38C05F-C1F5-46D0-B859-7F504C35DB73Q37031182-89D80A22-4734-454D-A177-A0371CAD2231Q38932726-66BB82B4-2F2C-4836-8B30-49486B88CDE8Q39363389-056500C6-4908-4F2D-A2C9-02E70E34B09CQ40768310-6B7174A0-819E-43FB-B12F-899E484CC2E4Q41449942-54CEF14E-7746-4711-8271-E9AEB5F4D21BQ42370473-99FDA536-9D1A-495E-8A80-92500B8EB028Q46256360-2A700170-0001-4A13-9733-B929C996288DQ46523185-BD2A0AA5-1962-4AEE-950B-732AF9517007Q47104940-2ACFE320-446C-4A12-A9DD-2A488232C53BQ47249062-AA707DE6-144C-4705-86E7-7D303C5193BDQ50055420-D24D45D2-B70C-4914-A3D1-EDAAFC891C74Q50532218-80A4FF9B-A732-4D47-9181-1D53A5705E9CQ55515243-3CD1B926-A32A-4C43-827B-501BCC4EA572Q58697876-5129C594-868E-4DA3-B2E3-36FA888F0A6B
P2860
Probiotics as Complementary Treatment for Metabolic Disorders
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Probiotics as Complementary Treatment for Metabolic Disorders
@ast
Probiotics as Complementary Treatment for Metabolic Disorders
@en
Probiotics as Complementary Treatment for Metabolic Disorders
@nl
type
label
Probiotics as Complementary Treatment for Metabolic Disorders
@ast
Probiotics as Complementary Treatment for Metabolic Disorders
@en
Probiotics as Complementary Treatment for Metabolic Disorders
@nl
prefLabel
Probiotics as Complementary Treatment for Metabolic Disorders
@ast
Probiotics as Complementary Treatment for Metabolic Disorders
@en
Probiotics as Complementary Treatment for Metabolic Disorders
@nl
P2093
P2860
P50
P3181
P1476
Probiotics as Complementary Treatment for Metabolic Disorders
@en
P2093
André Marette
Emile Levy
Fernando F Anhê
Mélanie Le Barz
Thibaut V Varin
P2860
P304
P3181
P356
10.4093/DMJ.2015.39.4.291
P407
P577
2015-08-01T00:00:00Z